GemVax & KAEL Co Ltd
KOSDAQ:082270
GemVax & KAEL Co Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9 900
49 500
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does GemVax & KAEL Co Ltd hold over its rivals?
What risks and challenges
does GemVax & KAEL Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of GemVax & KAEL Co Ltd.
Provide an overview of the primary business activities
of GemVax & KAEL Co Ltd.
What unique competitive advantages
does GemVax & KAEL Co Ltd hold over its rivals?
What risks and challenges
does GemVax & KAEL Co Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for GemVax & KAEL Co Ltd.
Provide P/S
for GemVax & KAEL Co Ltd.
Provide P/E
for GemVax & KAEL Co Ltd.
Provide P/OCF
for GemVax & KAEL Co Ltd.
Provide P/FCFE
for GemVax & KAEL Co Ltd.
Provide P/B
for GemVax & KAEL Co Ltd.
Provide EV/S
for GemVax & KAEL Co Ltd.
Provide EV/GP
for GemVax & KAEL Co Ltd.
Provide EV/EBITDA
for GemVax & KAEL Co Ltd.
Provide EV/EBIT
for GemVax & KAEL Co Ltd.
Provide EV/OCF
for GemVax & KAEL Co Ltd.
Provide EV/FCFF
for GemVax & KAEL Co Ltd.
Provide EV/IC
for GemVax & KAEL Co Ltd.
What are the Revenue projections
for GemVax & KAEL Co Ltd?
How accurate were the past Revenue estimates
for GemVax & KAEL Co Ltd?
What are the Net Income projections
for GemVax & KAEL Co Ltd?
How accurate were the past Net Income estimates
for GemVax & KAEL Co Ltd?
What are the EPS projections
for GemVax & KAEL Co Ltd?
How accurate were the past EPS estimates
for GemVax & KAEL Co Ltd?
What are the EBIT projections
for GemVax & KAEL Co Ltd?
How accurate were the past EBIT estimates
for GemVax & KAEL Co Ltd?
Compare the revenue forecasts
for GemVax & KAEL Co Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of GemVax & KAEL Co Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of GemVax & KAEL Co Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of GemVax & KAEL Co Ltd compared to its peers.
Compare the P/E ratios
of GemVax & KAEL Co Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing GemVax & KAEL Co Ltd with its peers.
Analyze the financial leverage
of GemVax & KAEL Co Ltd compared to its main competitors.
Show all profitability ratios
for GemVax & KAEL Co Ltd.
Provide ROE
for GemVax & KAEL Co Ltd.
Provide ROA
for GemVax & KAEL Co Ltd.
Provide ROIC
for GemVax & KAEL Co Ltd.
Provide ROCE
for GemVax & KAEL Co Ltd.
Provide Gross Margin
for GemVax & KAEL Co Ltd.
Provide Operating Margin
for GemVax & KAEL Co Ltd.
Provide Net Margin
for GemVax & KAEL Co Ltd.
Provide FCF Margin
for GemVax & KAEL Co Ltd.
Show all solvency ratios
for GemVax & KAEL Co Ltd.
Provide D/E Ratio
for GemVax & KAEL Co Ltd.
Provide D/A Ratio
for GemVax & KAEL Co Ltd.
Provide Interest Coverage Ratio
for GemVax & KAEL Co Ltd.
Provide Altman Z-Score Ratio
for GemVax & KAEL Co Ltd.
Provide Quick Ratio
for GemVax & KAEL Co Ltd.
Provide Current Ratio
for GemVax & KAEL Co Ltd.
Provide Cash Ratio
for GemVax & KAEL Co Ltd.
What is the historical Revenue growth
over the last 5 years for GemVax & KAEL Co Ltd?
What is the historical Net Income growth
over the last 5 years for GemVax & KAEL Co Ltd?
What is the current Free Cash Flow
of GemVax & KAEL Co Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for GemVax & KAEL Co Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
KR |
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
1.9T KRW | -58.6 | |
NL |
![]() |
ASML Holding NV
AEX:ASML
|
258B EUR | 25.1 |
|
US |
B
|
Brooks Automation Inc
LSE:0HQ1
|
244.2B USD | 7 769.4 |
|
US |
![]() |
Applied Materials Inc
NASDAQ:AMAT
|
128B USD | 14.4 |
|
US |
![]() |
Lam Research Corp
NASDAQ:LRCX
|
106.2B USD | 18.4 |
|
US |
![]() |
KLA Corp
NASDAQ:KLAC
|
101.1B USD | 19.7 |
|
JP |
![]() |
Tokyo Electron Ltd
TSE:8035
|
10.8T JPY | 14.7 |
|
JP |
![]() |
Advantest Corp
TSE:6857
|
5.4T JPY | 20.2 |
|
CN |
![]() |
NAURA Technology Group Co Ltd
SZSE:002371
|
223.3B CNY | 30.6 |
|
NL |
![]() |
ASM International NV
AEX:ASM
|
23.7B EUR | 20.8 |
|
JP |
![]() |
Disco Corp
TSE:6146
|
3.6T JPY | 18.7 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
KR |
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
Average EV/EBITDA:
795.2
|
N/A | N/A | |
NL |
![]() |
ASML Holding NV
AEX:ASML
|
25.1
|
18%
|
1.4 |
|
US |
B
|
Brooks Automation Inc
LSE:0HQ1
|
7 769.4
|
77%
|
100.9 |
|
US |
![]() |
Applied Materials Inc
NASDAQ:AMAT
|
14.4
|
9%
|
1.6 |
|
US |
![]() |
Lam Research Corp
NASDAQ:LRCX
|
18.4
|
16%
|
1.2 |
|
US |
![]() |
KLA Corp
NASDAQ:KLAC
|
19.7
|
14%
|
1.4 |
|
JP |
![]() |
Tokyo Electron Ltd
TSE:8035
|
14.7
|
22%
|
0.7 |
|
JP |
![]() |
Advantest Corp
TSE:6857
|
20.2
|
17%
|
1.2 |
|
CN |
![]() |
NAURA Technology Group Co Ltd
SZSE:002371
|
30.6
|
31%
|
1 |
|
NL |
![]() |
ASM International NV
AEX:ASM
|
20.8
|
18%
|
1.2 |
|
JP |
![]() |
Disco Corp
TSE:6146
|
18.7
|
8%
|
2.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.